Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Tremelimumab 300 / Durvalumab 1500, Hepatocellular Carcinoma, Cycle 1

Protocol-ID: 2288 V1.0 (Mini), TREM300/DURV1500, HCC, C1

Indication(s)

  • Hepatocellular Carcinoma; ICD-10 C22.0
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.03.2023